Dacarbazine Injection

This injection contains Dacarbazine and belongs to the group of alkylating antineoplastic agent products. It is used in the management of metastatic malignant melanoma and hodgkin lymphoma, in line with standard clinical indications for this class.

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.